The aim of this study was to verify whether abnormalities in plasma amino acid (AA) levels could be biological correlates of the age of onset in amyotrophic lateral sclerosis (ALS). We undertook plasma AA profiling in a large population comprising 117 newly diagnosed ALS patients and 117 matched controls. ALS patients were stratified in early (58 patients aged 74 years). We applied a rapid and reproducible method for the analysis of AA using amine reactive isotope coded tags in conjunction with liquid chromatography coupled to Multiple Reaction Monitoring-Mass Spectrometry. Results showed that values of only three AA were significantly different in ALS patients and controls. We found lower levels of leucine and higher levels of glutamate a...
Amyotrophic lateral sclerosis (ALS) is a fatal neurodegenerative disease characterized by a progress...
Amyotrophic lateral sclerosis (ALS) is a fatal neurodegenerative disease characterized by a progress...
Mass spectrometry was used to study blood samples from patients with amyotrophic lateral sclerosis (...
The aim of this study was to verify whether abnormalities in plasma amino acid (AA) levels could be ...
Objective: To assess whether prediagnostic levels of plasma branched-chain amino acids (BCAAs) are a...
Objective: To identify prediagnostic plasma metabolomic biomarkers associated with amyotrophic later...
AbstractThe development of therapies for Amyotrophic Lateral Sclerosis (ALS) has been hindered by th...
ALS is a heterogeneous disease that is not well understood. Epigenetic rearrangements are important ...
Abstract To identify differential metabolites and metabolic pathways and provide guidance for the no...
Objective: Little is known whether disease clinical stage would influence the serological values in ...
Recent studies using mass spectrometry have discovered candidate biomarkers for amyotrophic lateral ...
BACKGROUND: N -acetylaspartate (NAA) level is a biomarker of functional integrity and vitality in ...
Amyotrophic lateral sclerosis (ALS) is a fatal condition primarily characterized by the selective lo...
Background: Amyotrophic lateral sclerosis (ALS), an invariably fatal neurological disorder shows com...
Amyotrophic lateral sclerosis (ALS) is a multifactorial neurodegenerative pathology of the upper or ...
Amyotrophic lateral sclerosis (ALS) is a fatal neurodegenerative disease characterized by a progress...
Amyotrophic lateral sclerosis (ALS) is a fatal neurodegenerative disease characterized by a progress...
Mass spectrometry was used to study blood samples from patients with amyotrophic lateral sclerosis (...
The aim of this study was to verify whether abnormalities in plasma amino acid (AA) levels could be ...
Objective: To assess whether prediagnostic levels of plasma branched-chain amino acids (BCAAs) are a...
Objective: To identify prediagnostic plasma metabolomic biomarkers associated with amyotrophic later...
AbstractThe development of therapies for Amyotrophic Lateral Sclerosis (ALS) has been hindered by th...
ALS is a heterogeneous disease that is not well understood. Epigenetic rearrangements are important ...
Abstract To identify differential metabolites and metabolic pathways and provide guidance for the no...
Objective: Little is known whether disease clinical stage would influence the serological values in ...
Recent studies using mass spectrometry have discovered candidate biomarkers for amyotrophic lateral ...
BACKGROUND: N -acetylaspartate (NAA) level is a biomarker of functional integrity and vitality in ...
Amyotrophic lateral sclerosis (ALS) is a fatal condition primarily characterized by the selective lo...
Background: Amyotrophic lateral sclerosis (ALS), an invariably fatal neurological disorder shows com...
Amyotrophic lateral sclerosis (ALS) is a multifactorial neurodegenerative pathology of the upper or ...
Amyotrophic lateral sclerosis (ALS) is a fatal neurodegenerative disease characterized by a progress...
Amyotrophic lateral sclerosis (ALS) is a fatal neurodegenerative disease characterized by a progress...
Mass spectrometry was used to study blood samples from patients with amyotrophic lateral sclerosis (...